Top Markets
#1 Zora Zora +33.71%
#2 SAFEcoin SAFEcoin +32.79%
#3 0G 0G +20.57%
#4 QuantixAI QuantixAI +19.34%
#5 Full Moon Full Moon +18.56%
#6 Axelar Axelar +17.33%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.59%
#8 VVS Finance VVS Finance +15.88%
#9 SkyAI SkyAI +13.81%
#10 Apertum Apertum +13.61%
Coin of the day
Zora Zora
Настройки
Язык
Pусский
Валюта
USD
Тема
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Ранг среди акций #12783
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Цена акции
$5.87
Последняя синхронизация: 2022-11-08
Рыночная капитализация
$550.43M
Изменение (1 день)
1.03%
Изменение (1 год)
0.00%
Страна
US
Торговля Silverback Therapeutics, Inc. (SBTX)

Категория

Healthcare
Коэффициент P/B для Silverback Therapeutics, Inc. (SBTX)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Silverback Therapeutics, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Silverback Therapeutics, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH